X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10984) 10984
Book Review (1377) 1377
Publication (362) 362
Book Chapter (50) 50
Book / eBook (20) 20
Conference Proceeding (14) 14
Magazine Article (4) 4
Dissertation (3) 3
Data Set (2) 2
Government Document (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (10151) 10151
humans (8236) 8236
fibrinolysis - drug effects (5488) 5488
fibrinolysis (5432) 5432
male (4365) 4365
female (3902) 3902
animals (3249) 3249
middle aged (2756) 2756
adult (2488) 2488
hematology (2269) 2269
blood coagulation - drug effects (1981) 1981
peripheral vascular disease (1962) 1962
aged (1935) 1935
abridged index medicus (1298) 1298
coagulation (1254) 1254
time factors (1142) 1142
rats (1014) 1014
thrombosis (901) 901
cardiac & cardiovascular systems (709) 709
risk factors (690) 690
fibrin (685) 685
rabbits (683) 683
blood coagulation (670) 670
dose-response relationship, drug (669) 669
blood coagulation tests (667) 667
treatment outcome (667) 667
surgery (658) 658
fibrinolysis - physiology (652) 652
plasma (628) 628
fibrinolytic agents - therapeutic use (627) 627
hemostasis (610) 610
thrombolysis (607) 607
thrombin (600) 600
in vitro techniques (591) 591
mice (578) 578
fibrinolytic agents - pharmacology (566) 566
thrombolytic therapy (558) 558
fibrin - metabolism (511) 511
adolescent (504) 504
fibrinogen (498) 498
platelet aggregation - drug effects (485) 485
prospective studies (483) 483
hemostasis - drug effects (476) 476
fibrinogen - metabolism (473) 473
plasminogen-activator (472) 472
inflammation (469) 469
pharmacology & pharmacy (464) 464
tissue plasminogen activator (443) 443
myocardial-infarction (441) 441
risk (440) 440
fibrinogen - analysis (437) 437
thrombosis - drug therapy (429) 429
blood coagulation, fibrinolysis and cellular haemostasis (418) 418
double-blind method (415) 415
blood platelets - drug effects (409) 409
analysis (408) 408
therapy (406) 406
aged, 80 and over (403) 403
myocardial infarction - drug therapy (399) 399
dogs (398) 398
plasminogen - metabolism (392) 392
plasminogen activator inhibitor 1 - blood (392) 392
acute myocardial-infarction (383) 383
kinetics (378) 378
heparin - pharmacology (376) 376
tissue plasminogen activator - metabolism (376) 376
blood (375) 375
activation (372) 372
plasminogen (369) 369
tissue plasminogen activator - blood (368) 368
cells, cultured (364) 364
disease models, animal (362) 362
tissue plasminogen activator - therapeutic use (356) 356
urokinase (348) 348
care and treatment (342) 342
anticoagulants - therapeutic use (336) 336
anticoagulants (330) 330
disease (329) 329
research (325) 325
fibrinolytic agents - administration & dosage (324) 324
thrombelastography (322) 322
heparin - therapeutic use (320) 320
heparin (318) 318
mortality (318) 318
biochemistry & molecular biology (310) 310
medicine & public health (310) 310
streptokinase - therapeutic use (307) 307
fibrinolysin - metabolism (301) 301
tissue plasminogen activator - pharmacology (300) 300
biomarkers - blood (297) 297
stroke (287) 287
platelets (286) 286
cardiopulmonary bypass (285) 285
health aspects (285) 285
thrombin - metabolism (284) 284
medicine, general & internal (283) 283
expression (281) 281
plasminogen activator inhibitor 1 - metabolism (281) 281
plasminogen-activator inhibitor-1 (273) 273
injections, intravenous (269) 269
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9371) 9371
Russian (587) 587
German (437) 437
Japanese (129) 129
Italian (128) 128
French (112) 112
Polish (107) 107
Spanish (62) 62
Chinese (30) 30
Czech (15) 15
Ukrainian (15) 15
Romanian (10) 10
Swedish (8) 8
Danish (7) 7
Dutch (7) 7
Portuguese (7) 7
Slovak (5) 5
Turkish (5) 5
Bulgarian (4) 4
Croatian (4) 4
Hungarian (4) 4
Serbian (3) 3
Finnish (2) 2
Norwegian (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 09/2007, Volume 357, Issue 11, pp. 1075 - 1082
After exposure to dilute diesel exhaust, men with coronary disease had increased exercise-induced myocardial ischemia, along with depressed fibrinolytic... 
IMPAIRED ENDOGENOUS FIBRINOLYSIS | MEDICINE, GENERAL & INTERNAL | MYOCARDIAL-INFARCTION | ENDOTHELIAL DYSFUNCTION | TERM EXPOSURE | PARTICLES | INFLAMMATORY RESPONSES | ST-SEGMENT DEPRESSION | PARTICULATE AIR-POLLUTION | US CITIES | FINE | Fibrinolysis - drug effects | Vehicle Emissions - toxicity | Vasodilator Agents - pharmacology | Double-Blind Method | Humans | Middle Aged | Particulate Matter - adverse effects | Air Pollution - adverse effects | Coronary Disease - physiopathology | Male | Cardiovascular System - drug effects | Inhalation | Cross-Over Studies | Environmental Exposure - adverse effects | Cardiovascular System - physiopathology | Myocardial Infarction | Myocardial Ischemia - etiology | Thrombosis - etiology | Exercise - physiology | Causes of | Air pollution | Coronary heart disease | Risk factors | Cardiovascular disease | Heart attacks | Angina pectoris | Index Medicus | Abridged Index Medicus | Medical and Health Sciences | Thrombosis/etiology | Medicin och hälsovetenskap | Fibrinolysis/drug effects | Vehicle Emissions/toxicity | Exercise/physiology | Coronary Disease/physiopathology | Klinisk medicin | Myocardial Ischemia/etiology | Air Pollution/adverse effects | Kardiologi | Vasodilator Agents/pharmacology | Clinical Medicine | Cardiac and Cardiovascular Systems | Particulate Matter/adverse effects | Cardiovascular System/drug effects/physiopathology | Environmental Exposure/adverse effects
Journal Article
Stroke, ISSN 0039-2499, 11/2015, Volume 46, Issue 11, pp. 3241 - 3248
Journal Article
European Heart Journal, ISSN 0195-668X, 11/2011, Volume 32, Issue 21, pp. 2660 - 2671
Journal Article
Gut, ISSN 0017-5749, 09/2017, Volume 66, Issue 9, pp. 1623 - 1630
ObjectiveThe gut microbiota is essential for the development of the intestinal immune system. Animal models have suggested that the gut microbiota also acts as... 
Enteric Bacterial Microflora | Sepsis | Antibiotics | Endotoxin | Immune Response | FIBRINOLYSIS | HEMATOPOIESIS | INTESTINAL MICROBIOTA | IMMUNOSUPPRESSION | DISEASE | BACTERIAL-INFECTION | AZITHROMYCIN | GASTROENTEROLOGY & HEPATOLOGY | INNATE IMMUNITY | SEVERE SEPSIS | TRANSPLANTATION | Sepsis - immunology | Streptococcus pneumoniae - drug effects | Klebsiella pneumoniae - drug effects | Immunity, Innate - drug effects | Endotoxemia - drug therapy | Escherichia coli - drug effects | Humans | Ciprofloxacin - pharmacology | Male | Treatment Outcome | Healthy Volunteers | Metronidazole - pharmacology | Immunity, Innate - immunology | Sepsis - drug therapy | Gastrointestinal Microbiome - drug effects | Klebsiella pneumoniae - physiology | Vancomycin - pharmacology | Adult | Anti-Bacterial Agents - pharmacology | Gastrointestinal Microbiome - immunology | Drug Monitoring | Escherichia coli - physiology | Endotoxemia - microbiology | Streptococcus pneumoniae - physiology | Complications and side effects | Intestines | Immune response | Microbiota (Symbiotic organisms) | Analysis | Research | Intensive care | Animal models | Innate immunity | Vancomycin | Inflammatory diseases | Streptococcus infections | Lipopolysaccharides | Microbiota | Cell activation | E coli | Intestine | Rodents | Toll-like receptors | Chronic obstructive pulmonary disease | Digestive tract | Endotoxemia | Immune system | Digestive system | Principal components analysis | Immunosuppression | Metronidazole | Ciprofloxacin | Index Medicus | Abridged Index Medicus
Journal Article
Diabetes Care, ISSN 0149-5992, 07/2010, Volume 33, Issue 7, pp. 1591 - 1597
OBJECTIVE - To examine the effects of acute insulin-induced hypoglycemia on inflammation, endothelial dysfunction, and platelet activation in adults with and... 
FIBRINOLYSIS | CELLS | GLUCOSE | ENDOCRINOLOGY & METABOLISM | ATHEROSCLEROSIS | COMPLICATIONS | PLATELET ACTIVATION | Inflammation - chemically induced | Vasculitis - metabolism | Blood Platelets - immunology | CD40 Ligand - blood | Humans | Platelet Activation - immunology | Diabetes Mellitus, Type 1 - metabolism | Hypoglycemia - immunology | Endothelium, Vascular - drug effects | Male | Monocytes - immunology | Vasculitis - immunology | Inflammation - metabolism | C-Reactive Protein - metabolism | Flow Cytometry | Hypoglycemic Agents - administration & dosage | Interleukin-6 - blood | Adult | Female | Diabetes Mellitus, Type 1 - immunology | Hypoglycemia - chemically induced | Endothelium, Vascular - immunology | von Willebrand Factor - metabolism | Diabetic Angiopathies - metabolism | Insulin - administration & dosage | Inflammation - immunology | Biomarkers - blood | Diabetic Angiopathies - drug therapy | Hypoglycemia - metabolism | Tissue Plasminogen Activator - blood | Diabetes Mellitus, Type 1 - drug therapy | Blood Glucose - drug effects | Diabetic Angiopathies - immunology | P-Selectin - blood | CD40 Antigens - blood | Platelet Activation - drug effects | Blood Glucose - metabolism | Hypoglycemic Agents - adverse effects | Insulin - adverse effects | Blood circulation disorders | Diabetics | C-reactive protein | Type 1 diabetes | Blood sugar | Tissue plasminogen activator | Analysis | Von Willebrand factor | Inflammation | Research | Diabetes | Biomarkers | Flow cytometry | Family medical history | Research & development--R&D | Mortality | Index Medicus | Original Research
Journal Article
1984, A Wiley medical publication, ISBN 0471905623, xiv, 180
Book
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2015, Volume 10, Issue 4, pp. e0123982 - e0123982
Macrophages play crucial roles in repair process of various tissues. However, the details in the role of macrophages during bone repair still remains unknown.... 
CELLS | OSTEOCLASTS | GENE | ANGIOGENESIS | INFLAMMATORY PROTEIN-1-ALPHA | MULTIDISCIPLINARY SCIENCES | OSTEOBLASTS | PLASMINOGEN-ACTIVATOR INHIBITOR-1 | RECEPTOR | ENDOTHELIAL GROWTH-FACTOR | UROKINASE | Fibrinolysis - drug effects | Femur - pathology | Tissue Plasminogen Activator - metabolism | Cartilage - pathology | Femur - blood supply | Cell Count | Chemokine CCL4 - genetics | Male | Plasminogen - metabolism | Cartilage - drug effects | RNA, Messenger - metabolism | Chemokine CCL3 - genetics | Time Factors | Chemokine CCL3 - metabolism | Chemokine CCL4 - metabolism | Chemokine CCL2 - metabolism | Wound Healing - drug effects | Phagocytosis - drug effects | Osteoblasts - drug effects | RNA, Messenger - genetics | Antibodies, Neutralizing - pharmacology | Chemokine CCL2 - genetics | Femur - drug effects | Osteoclasts - metabolism | Gene Expression Regulation - drug effects | Transcription Factors - metabolism | Macrophages - metabolism | Animals | Urokinase-Type Plasminogen Activator - metabolism | Sp7 Transcription Factor | Macrophages - drug effects | Mice | Osteoblasts - metabolism | Osteoclasts - drug effects | Tissue Plasminogen Activator - deficiency | Urokinase-Type Plasminogen Activator - deficiency | Plasminogen - deficiency | RNA | Macrophages | Femur | Multiple myeloma | Tissues | Defects | Recruitment | Proteins | Angiogenesis | Urokinase | Elevation | Physiology | Life sciences | Repair | Vascular endothelial growth factor | Immunoglobulins | Cytokines | Roles | IL-1β | Medicine | Injury prevention | Fractures | Bone | University faculty | Laboratory animals | Chemokines | Phagocytosis | Neutralization | Index Medicus
Journal Article
Critical Care, ISSN 1364-8535, 12/2013, Volume 17, Issue 6, pp. R297 - R297
Journal Article